Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03085069
What this trial is testing

Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms Nec+4 more
Jiangsu HengRui Medicine Co., Ltd. 146
Not applicableStudy completedNCT04929964
What this trial is testing

COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer

Who this might be right for
Covid19Breast Cancer StageIsolation, Social+1 more
Mehwish Mooghal , MBBS 87
Testing effectiveness (Phase 2)WithdrawnNCT01913067
What this trial is testing

Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC

Who this might be right for
Brain MetastasisBreast CancerNon Small Cell Lung Cancer
Jules Bordet Institute
Not applicableLooking for participantsNCT05599412
What this trial is testing

Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

Who this might be right for
Metastatic ALK+ Non Small Cell Lung Cancer
Pfizer 600
Not applicableStudy completedNCT03429192
What this trial is testing

Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Tianjin Chest Hospital 2,653
Early research (Phase 1)Ended earlyNCT04622072
What this trial is testing

XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Sihuan Pharmaceutical Holdings Group Ltd. 21
Early research (Phase 1)Ended earlyNCT06599502
What this trial is testing

A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
AstraZeneca 17
Testing effectiveness (Phase 2)UnknownNCT03356600
What this trial is testing

Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer

Who this might be right for
Brain Metastases
Shanxi Province Cancer Hospital 44
Testing effectiveness (Phase 2)Study completedNCT03213665
What this trial is testing

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02696993
What this trial is testing

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 80
Not applicableEnded earlyNCT02005614
What this trial is testing

A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection

Who this might be right for
MelanomaRenal Cell CarcinomaSarcoma+5 more
Yale University 39
Testing effectiveness (Phase 2)Study completedNCT03547804
What this trial is testing

A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
The First Hospital of Jilin University 31
Testing effectiveness (Phase 2)UnknownNCT04808752
What this trial is testing

Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases

Who this might be right for
Lung Cancer
Zhejiang Cancer Hospital 63
Not applicableStudy completedNCT07111104
What this trial is testing

Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Hopitaux Prives de Metz, Groupe UNEOS 350
Testing effectiveness (Phase 2)Study completedNCT03184571
What this trial is testing

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer MetastaticNSCLC Stage IVAdenocarcinoma of Lung
BerGenBio ASA 99
Testing effectiveness (Phase 2)Looking for participantsNCT05841472
What this trial is testing

Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non Squamous Non Small Cell Lung Cancer
CrystalGenomics, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Not applicableUnknownNCT00862173
What this trial is testing

Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer

Who this might be right for
Brain DiseaseMetastasisLung Cancer
National Institute of Cancerología 120
Testing effectiveness (Phase 2)Study completedNCT04838548
What this trial is testing

Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Lepu Biopharma Co., Ltd. 87
Not applicableUnknownNCT06613308
What this trial is testing

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Capital Medical University 20
Next Page